Free Virtual Consultations. Corona Virus Related Cases Click Here.

Chalacan Flores Killed in Crash on Pomona Freeway Near Market Street

Victim Dies in Multi-Vehicle Accident in Riverside

Riverside, CA (April 5, 2020) – One person was killed in a crash in Riverside. The fatal accident occurred on the evening of April 5 on the Pomona Freeway.

A high-occupancy vehicle crashed on the westbound Pomona Freeway, near Market Street. A truck and a sedan were involved in the crash. Several people exited the wrecked vehicle and stood on the side of the road. Redlands resident Chalacan Flores, 25, died in the accident.

Our heartfelt condolences go out to the friends and loved ones of Chalacan Flores.



January 10, 2020

1 Killed, 1 Injured in Crash on the 60 Freeway at Crossroads Parkway

Fiery Multi-Vehicle Crash in City of Industry Leads to Fatality...

October 18, 2019

Motorcyclist Injured in Crash on Highway 4 Near Port Chicago Highway

Man Injured in Hit and Run Accident in Concord Concord, CA (October 17, 2019) ...

May 21, 2020

Norma Aguilar Injured in Crash at Florin Road and 6th Parkway

1 Person Arrested in Sacramento Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.